4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Embolism, Pulmonary in 2 studies
WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, L | 1 |
| Peng, Z | 1 |
| Zhang, R | 2 |
| Liang, D | 1 |
| Chen, H | 1 |
| Tian, H | 1 |
| Uckun, FM | 1 |
| Vassilev, A | 1 |
| Bartell, S | 1 |
| Zheng, Y | 1 |
| Mahajan, S | 1 |
| Tibbles, HE | 1 |
2 other studies available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Embolism, Pulmonary
| Article | Year |
|---|---|
JANEX-1 improves acute pulmonary embolism through VEGF and FAK in pulmonary artery smooth muscle cells.
Topics: Acute Disease; Animals; Cell Proliferation; Disease Models, Animal; Focal Adhesion Protein-Tyrosine | 2020 |
The anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism.
Topics: Adenosine Diphosphate; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Aspirin; Bleeding Time; | 2003 |